These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 9573684)

  • 21. Acute myeloid leukemia (AML-M2) with t(5;11)(q35;q13) and normal expression of cyclin D1.
    de Oliveira FM; Tone LG; Simões BP; Falcão RP; Brassesco MS; Sakamoto-Hojo ET; dos Santos GA; Marinato AF; Jácomo RH; Rego EM
    Cancer Genet Cytogenet; 2007 Jan; 172(2):154-7. PubMed ID: 17213025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rearrangement of the myeloid/lymphoid leukemia gene in therapy-related myelodysplastic syndrome in patients previously treated with agents targeting DNA topoisomerase II.
    Mosad E; Abdou M; Zaky AH
    Oncology; 2012; 83(3):128-34. PubMed ID: 22814291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial duplication of HRX in acute leukemia with trisomy 11.
    Bernard OA; Romana SP; Schichman SA; Mauchauffé M; Jonveaux P; Berger R
    Leukemia; 1995 Sep; 9(9):1487-90. PubMed ID: 7658717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid leukemia after hematotoxins.
    Larson RA; LeBeau MM; Vardiman JW; Rowley JD
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1303-7. PubMed ID: 9118910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group.
    Ross JA; Potter JD; Reaman GH; Pendergrass TW; Robison LL
    Cancer Causes Control; 1996 Nov; 7(6):581-90. PubMed ID: 8932918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary acute myeloblastic leukaemia (AML) (expressing 11q23 mutation) occurring 11 months after chemotherapy/radiotherapy for paediatric non-Hodgkin lymphoma (NHL).
    Taylor HJ; Gravett P; Plowman PN
    Clin Oncol (R Coll Radiol); 2000; 12(2):112-4. PubMed ID: 10853750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding.
    Le H; Singh S; Shih SJ; Du N; Schnyder S; Loredo GA; Bien C; Michaelis L; Toor A; Diaz MO; Vaughan AT
    Genes Chromosomes Cancer; 2009 Sep; 48(9):806-15. PubMed ID: 19530238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematologic aspects of myeloablative therapy and bone marrow transplantation.
    Riley RS; Idowu M; Chesney A; Zhao S; McCarty J; Lamb LS; Ben-Ezra JM
    J Clin Lab Anal; 2005; 19(2):47-79. PubMed ID: 15756708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MLL/AF-1p fusion in therapy-related early pre-B acute lymphoblastic leukemia with t(1;11)(p32;q23) translocation developing in the relapse phase of acute promyelocytic leukemia.
    Tsujioka T; Wada H; Yamamori S; Otsuki T; Suemori S; Kondo T; Nakanishi H; Suetsugu Y; Mikami M; Sugihara T
    Int J Hematol; 2003 Dec; 78(5):439-42. PubMed ID: 14704037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
    Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
    Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome translocations: good genes gone wrong.
    Rowley JD
    Pathol Biol (Paris); 1995 Mar; 43(3):197-201. PubMed ID: 7675546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joining.
    Coiteux V; Onclercq-Delic R; Fenaux P; Amor-Guéret M
    Leuk Res; 2007 Mar; 31(3):353-8. PubMed ID: 16890283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].
    Dassonneville L; Bailly C
    Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy-related acute leukemia associated with involvement of 11q23 after high grade non-Hodgkin lymphoma.
    Martinelli G; Testoni N; Zinzani PL; Biondi A; Cimino G; Tura S
    Haematologica; 1998 Mar; 83(3):283-4. PubMed ID: 9573684
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.